How to Read a Clinical Trial: A Non-Scientist's Guide
Most arguments about repurposed drugs are really arguments about evidence quality. How to open a study, find what matters, and judge for yourself.
Read Article →Research updates, new findings, and in-depth analysis. Each article cites primary sources — no speculation, no sensationalism. Follow @RHarlan2026 for alerts.
Most arguments about repurposed drugs are really arguments about evidence quality. How to open a study, find what matters, and judge for yourself.
Read Article →A compound can have a plausible mechanism, kill cancer cells in a dish, shrink tumours in mice — and still fail completely in humans. Why.
Read Article →A single widely-shared story launched worldwide interest in fenbendazole. Examining it is the best available lesson in what anecdotes can establish.
Read Article →The polygraph's most serious flaw is not that guilty people beat it. It is that truthful people fail it — in far larger numbers than most assume.
Read Article →A step-by-step walkthrough of an examination, from arrival to scoring — including the phase that matters most and is least understood.
Read Article →Most drivers pay the fine because court sounds intimidating and the ticket seems cheap. Both assumptions are usually wrong.
Read Article →If you suspect a tracker on your vehicle, random searching will miss it. Trackers go in predictable places — and a systematic sweep is what finds them.
Read Article →Speed-measurement devices are treated in court as infallible. A technical primer on how they work, and where a reading can be challenged.
Read Article →Most drivers plead guilty without ever seeing the evidence against them. Disclosure is where traffic cases are most often won.
Read Article →The most authoritative scientific review ever conducted on lie detection reached a conclusion the industry would rather you did not read.
Read Article →What the National Cancer Institute's own screening data shows about antiparasitic compounds — and what it does not show.
Read Article →The dosing regimens that appear in the published literature, and the critical difference between a research protocol and a treatment.
Read Article →How cell-site simulators impersonate legitimate towers, what the public record reveals about their deployment, and how detection works.
Read Article →The three technologies used to track vehicles at scale, how each works, and what the documented countermeasures are.
Read Article →Metadata is treated as less sensitive than content. The record suggests it is often far more revealing.
Read Article →